Marshall Wace North America’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-865,538
| Closed | -$8.8M | – | 1394 |
|
|
2021
Q1 | $8.8M | Sell |
865,538
-1,932,985
| -69% | -$19.7M | 0.04% | 420 |
|
|
2020
Q4 | $20.8M | Buy |
2,798,523
+1,317,865
| +89% | +$9.82M | 0.09% | 244 |
|
|
2020
Q3 | $5.09M | Hold |
1,480,658
| – | – | 0.03% | 385 |
|
|
2020
Q2 | $7.05M | Buy |
+1,480,658
| New | +$7.05M | 0.05% | 319 |
|
|
2017
Q4 | – | Sell |
-84,895
| Closed | -$424K | – | 1372 |
|
|
2017
Q3 | $424K | Buy |
+84,895
| New | +$424K | ﹤0.01% | 1100 |
|